NEUROSCIENCES DISCOVERY SERVICES
COVERING MAJOR NEUROSCIENCE FIELDS IN R&D
The challenges posed for drug discovery and development in Neuroscience require innovation and a multi-disciplinary approach to develop drugs capable of crossing or bypassing the blood-brain barrier.
From drug discovery to regulatory approval, VectorB2B offers state-of-the art facilities, a full range of services, and the scientific expertise to discover and develop novel therapies in Neurosciences.
The VectorB2B consortium harbours a wealth of expertise in neuroscience and neurological diseases that include Alzheimer’s or Parkinson´s disease, autism, multiple sclerosis, amongst others.
We offer a low risk “one stop shop” for large- or small-scale projects, made possible by the depth of experience and expertise of VectorB2B scientific team. VectorB2B will deliver high quality custom or standard drug discovery solutions on time and on budget.